# FDA Inspection 755925 - Prof. Tadeusz Jerzy Robak, MD - October 21, 2011

Source: https://www.keypedia.com/records/fda_inspections/prof-tadeusz-jerzy-robak-md/52352ee4-f079-41ca-bc56-059eb0ca0a53
Source feed: FDA_Inspections

> FDA Inspection 755925 for Prof. Tadeusz Jerzy Robak, MD on October 21, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 755925
- Company Name: Prof. Tadeusz Jerzy Robak, MD
- Inspection Date: 2011-10-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1083035 - 2019-02-22](https://www.keypedia.com/records/fda_inspections/prof-tadeusz-jerzy-robak-md/feb231d9-9c76-41f7-98a8-9ac5eac06d89)
- [FDA Inspection 947109 - 2015-11-06](https://www.keypedia.com/records/fda_inspections/prof-tadeusz-jerzy-robak-md/bfcf9a48-2ba1-437d-af83-dae7f1e9981c)

Company: https://www.keypedia.com/companies/prof-tadeusz-jerzy-robak-md/d2f823f9-88b2-4953-a323-9151f4f98f77

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c